RGEN logo

Repligen (RGEN)

Profile

Full Name

Repligen Corporation

Ticker Symbol

RGEN

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

April 29, 1986

Indexes

Not included

Website

http://www.repligen.com

Employees

1778

Key Details

Price

$126.44(+1.66%)

Market cap

$7.10B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$634.44M(+0.33% YoY)

Annual EPS

-$0.46(-173.02% YoY)

PE ratio

-

Next earnings date

Jul 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $126.44
    RGEN price is $126.44

    30-Day Relative Volume

    0.84
    RGEN 30-day relative volume is 0.84

    Price Performance

    Price Most recent change

    +1.66%
    RGEN price was up +1.66% on Jul 1, 2025

    Price YTD change

    -12.16%
    RGEN price is down -12.16% since January 1st

    Price 1-year change

    +5.24%
    RGEN price is up +5.24% year-on-year

    Price 3-year change

    -24.07%
    RGEN price is down -24.07% over the past 3 years

    Price Range

    Price All-time high

    $327.32
    RGEN price is currently -61.37% below its historical high of $327.32

    Price 3-year low

    $102.97
    RGEN price is currently +22.79% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $7.10B
    RGEN market capitalization is $7.10 billion

    Market cap 3-year change

    -23.09%
    RGEN market capitalization is down -23.09% over the past 3 years

    Market cap All-time high

    $17.82B
    RGEN market capitalization is currently -60.15% below its historical high of $17.82 billion

    Market cap sector rank

    90.83%
    RGEN market capitalization is higher than 90.83% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.5%
    RGEN shares outstanding is up +0.5% year-on-year

    Shares Outstanding 3-Year Change

    +1.29%
    RGEN shares outstanding is up +1.29% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.35
    RGEN beta is 1.35

    200-day SMA

    $141.42
    RGEN price is currently -10.59% below its 200-day simple moving average

    50-day SMA

    $128.40
    RGEN price is currently -1.53% below its 50-day simple moving average

    RSI

    52.31
    RGEN 14-day relative strength index is 52.31

    Volume

    0.84
    RGEN 30-day relative volume is 0.84

    ATR

    $5.14
    RGEN average true range is $5.14

    10-day Historical Volatility

    32.57%
    RGEN 10-day historical volatility is 32.57%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $634.44M
    RGEN annual revenue is $634.44 million

    Revenue Analysts estimate

    $709.14M
    RGEN annual revenue is currently -10.53% lower than the consensus analysts' forecast

    Revenue 1-year change

    +0.33%
    RGEN annual revenue is up +0.33% year-on-year

    Revenue Sector rank

    76.27%
    RGEN annual revenue is higher than 76.27% of companies in Healthcare sector

    EPS

    EPS

    -$0.46
    RGEN annual earnings per share is -$0.46

    EPS Analysts estimate

    $1.68
    RGEN annual earnings per share is currently -127.34% lower than the consensus analysts' forecast

    EPS 1-year change

    -173.02%
    RGEN annual earnings per share is down -173.02% year-on-year

    EPS Sector rank

    69.36%
    RGEN annual earnings per share is higher than 69.36% of companies in Healthcare sector

    Profit

    Gross profit

    $274.64M
    RGEN annual gross profit is $274.64 million

    Gross margin

    43.29%
    RGEN annual gross profit margin is 43.29%

    Operating profit

    -$31.92M
    RGEN annual operating income is -$31.92 million

    Operating margin

    -5.03%
    RGEN annual operating profit margin is -5.03%

    Net income

    -$25.51M
    RGEN annual net profit is -$25.51 million

    Net margin

    -4.02%
    RGEN annual net profit margin is -4.02%

    Expenses

    Total expenses

    $666.36M
    RGEN annual total expenses is $666.36 million

    Operating expenses

    $306.57M
    RGEN annual total operating expenses is $306.57 million

    Cost of goods sold

    $359.79M
    RGEN annual cost of goods sold is $359.79 million

    Selling, general & administrative expenses

    $263.37M
    RGEN annual SGA is $263.37 million

    Depreciation and amortization

    $86.56M
    RGEN annual depreciation & amortization is $86.56 million

    Interest expense

    $20.73M
    RGEN annual interest expense is $20.73 million

    Income tax

    -$1.52M
    RGEN annual income tax is -$1.52 million

    EBIT & EBITDA

    EBIT

    -$6.30M
    RGEN annual earnings before interest & taxes is -$6.30 million

    EBITDA

    -$6.30M
    RGEN annual EBITDA is -$6.30 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $2.83B
    RGEN annual total assets is $2.83 billion

    Non current assets

    $1.76B
    RGEN annual long term assets is $1.76 billion

    Current assets

    $1.07B
    RGEN annual total current assets is $1.07 billion

    Cash and cash equivalents

    $757.36M
    RGEN annual cash & cash equivalents is $757.36 million

    Accounts receivable

    $134.12M
    RGEN annual accounts receivable is $134.12 million

    Inventory

    $142.96M
    RGEN annual inventory is $142.96 million

    Liabilities

    Total liabilities

    $856.95M
    RGEN annual total liabilities is $856.95 million

    Long term liabilities

    $730.16M
    RGEN annual total long term liabilities is $730.16 million

    Current liabilities

    $126.79M
    RGEN annual total current liabilities is $126.79 million

    Accounts payable

    $32.13M
    RGEN annual accounts payable is $32.13 million

    Debt

    Total debt

    $686.25M
    RGEN annual total debt is $686.25 million

    Total debt 1-year change

    -3.59%
    RGEN annual total debt is down -3.59% year-on-year

    Long term debt

    $671.14M
    RGEN annual long term debt is $671.14 million

    Short term debt

    $15.10M
    RGEN annual short term debt is $15.10 million

    Equity & Capital

    Shareholders equity

    $1.97B
    RGEN annual stockholders equity is $1.97 billion

    Book value

    $1.97B
    RGEN annual book value is $1.97 billion

    Retained earnings

    $407.35M
    RGEN annual retained earnings is $407.35 million

    Working capital

    $939.25M
    RGEN annual working capital is $939.25 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $175.39M
    RGEN annual cash flow from operations is $175.39 million

    Cash from operations 1-year change

    +53.97%
    RGEN annual cash flow from operations is up +53.97% year-on-year

    Cash from investing

    -$86.38M
    RGEN annual cash flow from investing activities is -$86.38 million

    Cash from investing 1-year change

    +29.93%
    RGEN annual cash flow from investing activities is up +29.93% year-on-year

    Cash from financing

    -$82.90M
    RGEN annual cash flow from financing activities is -$82.90 million

    Cash from financing 1-year change

    -133.3%
    RGEN annual cash flow from financing activities is down -133.3% year-on-year

    CAPEX

    CAPEX

    $32.91M
    RGEN annual capital expenditures is $32.91 million

    CAPEX 1-year change

    -15.6%
    RGEN annual capital expenditures is down -15.6% year-on-year

    Free Cash Flow

    Free cash flow

    $142.49M
    RGEN annual free cash flow is $142.49 million

    Free cash flow 1-year change

    +90.16%
    RGEN annual free cash flow is up +90.16% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    43.29%
    RGEN annual gross profit margin is 43.29%

    Operating margin

    -5.03%
    RGEN annual operating profit margin is -5.03%

    Net margin

    -4.02%
    RGEN annual net profit margin is -4.02%

    ROA & ROE

    ROA

    -0.90%
    RGEN annual return on assets is -0.90%

    ROE

    -1.30%
    RGEN annual return on equity is -1.30%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    RGEN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    RGEN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.58
    RGEN price to book ratio is 3.58

    PB ratio Sector rank

    72.89%
    RGEN price to book ratio is higher than 72.89% of companies in Healthcare sector

    PS Ratio

    PS ratio

    10.92
    RGEN price to sales ratio is 10.92

    PS ratio Sector rank

    79.34%
    RGEN price to sales ratio is higher than 79.34% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $7.09B
    RGEN enterprise value is $7.09 billion

    Enterprise value Sector rank

    89.85%
    RGEN enterprise value is higher than 89.85% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    81.86
    RGEN EV/EBITDA is 81.86

    EV/EBITDA Sector rank

    98.52%
    RGEN EV/EBITDA is higher than 98.52% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    8.41
    RGEN annual current ratio is 8.41

    Quick ratio

    7.28
    RGEN annual quick ratio is 7.28

    Leverage

    Debt to equity

    0.27
    RGEN annual debt to equity ratio is 0.27

    Interest coverage ratio

    -0.30
    RGEN annual interest coverage ratio is -0.30

    Risk & Stability

    Piotroski F-Score

    4
    RGEN piotroski f-score is 4

    Altman Z-Score

    5.79
    RGEN altman z-score is 5.79

    Analyst ratings

    Recent major analysts updates

    May 5, 25 HC Wainwright & Co.
    Buy
    Apr 30, 25 RBC Capital
    Outperform
    Apr 29, 25 JP Morgan
    Overweight
    Apr 17, 25 Canaccord Genuity
    Hold
    Apr 16, 25 Canaccord Genuity
    Hold
    Mar 18, 25 Evercore ISI Group
    In-Line
    Feb 21, 25 RBC Capital
    Outperform
    Feb 21, 25 JP Morgan
    Overweight
    Feb 21, 25 HC Wainwright & Co.
    Buy
    Feb 21, 25 Canaccord Genuity
    Hold

    Institutional Ownership

    Screeners with RGEN included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Repligen?
    • Does Repligen pay dividends?
    • What sector is Repligen in?
    • What industry is Repligen in?
    • What country is Repligen based in?
    • When did Repligen go public?
    • Is Repligen in the S&P 500?
    • Is Repligen in the NASDAQ 100?
    • Is Repligen in the Dow Jones?
    • When was Repligen's last earnings report?
    • When does Repligen report earnings?
    • Should I buy Repligen stock now?

    What is the ticker symbol for Repligen?

    The ticker symbol for Repligen is NASDAQ:RGEN

    Does Repligen pay dividends?

    No, Repligen does not pay dividends

    What sector is Repligen in?

    Repligen is in the Healthcare sector

    What industry is Repligen in?

    Repligen is in the Medical Instruments & Supplies industry

    What country is Repligen based in?

    Repligen is headquartered in United States

    When did Repligen go public?

    Repligen's initial public offering (IPO) was on April 29, 1986

    Is Repligen in the S&P 500?

    No, Repligen is not included in the S&P 500 index

    Is Repligen in the NASDAQ 100?

    No, Repligen is not included in the NASDAQ 100 index

    Is Repligen in the Dow Jones?

    No, Repligen is not included in the Dow Jones index

    When was Repligen's last earnings report?

    Repligen's most recent earnings report was on Apr 29, 2025

    When does Repligen report earnings?

    The next expected earnings date for Repligen is Jul 30, 2025

    Should I buy Repligen stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page